- https://www.novartis.com/news/novartis-financial-results-q1-2021
Novartis announced the company’s financial results for the first quarter of 2021.
- https://www.novartis.com/news/ruxcovid-clinical-trial
The RUXCOVID clinical trial highlights the Novartis commitment to leverage our expertise and resources to support the global response to the COVID-19 pandemic.
- https://www.novartis.com/news/study-suggests-there-may-be-two-stages-fatal-lung-disease-covid-19
NIBR translational immunologists and academic colleagues observe two distinct molecular patterns of disease progression in lung tissue samples.
- https://www.novartis.com/news/choice-responsibility-reimagining-how-we-work
- https://www.novartis.com/news/international-womens-day-2020
To celebrate International Women’s Day we explore how an inclusive environment that values unique and curious minds helps everyone be inspired to innovate every day.
- https://www.novartis.com/news/world-sight-day-2020
Learn how we’re working with partners like the International Agency for the Prevention of Blindness to eliminate preventable blindness.
- https://www.novartis.com/news/50-climate-leaders
At Novartis, we aim to be a leader in environmental sustainability and a catalyst for positive change both in our own operations and in our supply chain.
- https://www.novartis.com/news/new-report-shows-how-ai-health-critical-covid-19-response-and-recovery
AI offers the greatest potential to transform health systems from being reactive to proactive, predictive, and even preventive.
- https://www.novartis.com/news/world-sickle-cell-day-2020
Standing by people with sickle cell disease and their families
- https://www.novartis.com/news/novartis-asco
Latest oncology resources and news surrounding Novartis data featured at American Society of Clinical Oncology (ASCO)
Pagination
- ‹ Previous page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- …
- 20
- › Next page